Theriva Biologics, Inc. Deferred Income Tax Liabilities, Net
Theriva Biologics, Inc. (TOVX) had Deferred Income Tax Liabilities, Net of $413.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2024-03-25
- 2023-09-30: Deferred Income Tax Liabilities, Net $413.00K.
- 2023-06-30: Deferred Income Tax Liabilities, Net $952.00K.
- 2023-03-31: Deferred Income Tax Liabilities, Net $1.31M.
- 2022-12-31: Deferred Income Tax Liabilities, Net $1.62M.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2023-09-30 | $413.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $952.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.31M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.62M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $1.98M 10-K · filed 2023-03-30 | $3.49M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.29M 10-K · filed 2023-03-30 | $3.50M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.73M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |